Jackson Center, Pennsylvania--(Newsfile Corp. - March 1, 2022) - Halberd Corporation's (OTC Pink: HALB) previously developed SARS-CoV-2 antibody demonstrated superior binding capability to the ...
Halberd's patent position insured high potential of technical and market success. Halberd chose neurodegenerative diseases as its primary focus, since there are approximately 36 million people ...
Venturing to Fort Ironclad during the main story of Crimson Desert will eventually have you face Gregor, the Halberd of Carnage. This lethal boss utilizes his fast speed, aggression, and cannon fire ...
Mississippi State University (MSU) is well on their way in testing Halberd's patent-pending nasal spray to mitigate the neurological effects resulting from traumatic brain injuries (TBI). By directly ...
JACKSON CENTER, PA / ACCESSWIRE / October 18, 2022 / Halberd Corporation (OTC PINK:HALB) has successfully eliminated various antibiotic resistant bacteria from buffer solution in-vitro through the use ...
JACKSON CENTER, PA / ACCESSWIRE / September 27, 2022 / Halberd Corporation (OTC PINK:HALB) entered into a strategic alliance with AI Longevity, Inc. and Stem of Hope to form a strategic alliance as a ...
JACKSON CENTER, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Halberd Corporation (OTC-PINK: "HALB”) has announced encouraging preliminary outcomes from its Phase II testing at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results